Balansag, Angelica U.

HRN: 17-26-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
CEFUROXIME 1.5GM (VIAL)
08/28/2025
08/29/2025
IVTT
1.5g
Q8h
SP LTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines